Nanox Targets U.S. Southeast with Affordable 3D Imaging System

PETACH TIKVA, Israel – March 03, 2026 – In a strategic move poised to enhance diagnostic capabilities for orthopedic practices across the U.S. Southeast, Israeli medical imaging innovator Nano-X Imaging Ltd. has announced a significant distribution agreement. Through its U.S. subsidiary, Nanox has partnered with Imperial Imaging Technology, a rapidly growing distributor, to deploy its Nanox.ARC 3D tomosynthesis system across six states, targeting a region rich with orthopedic and musculoskeletal (MSK) service providers.

This collaboration marks a crucial step in Nanox's commercial rollout strategy in the United States, aiming to place advanced, cost-effective 3D imaging directly at the point of care. The agreement grants Imperial Imaging the rights to distribute the Nanox.ARC system in Georgia, Alabama, Tennessee, North Carolina, South Carolina, and Northern Florida, expanding access to a technology designed to bridge the gap between conventional 2D X-rays and more costly, higher-radiation CT scans.

A New Vision for Point-of-Care Imaging

The partnership directly addresses a growing demand within the orthopedic community for more efficient and powerful in-office diagnostic tools. For decades, orthopedic practices have relied on 2D X-rays for initial assessments, but this technology has inherent limitations, such as the superimposition of anatomical structures, which can obscure subtle fractures or complex joint issues. When a clearer image is needed, patients are typically sent to an external hospital or imaging center for a CT scan, a process that introduces delays, increases patient travel, and drives up healthcare costs.

The Nanox.ARC system is designed to disrupt this paradigm. As a digital tomosynthesis system, it captures a series of low-dose X-ray images from multiple angles and computationally reconstructs them into three-dimensional slices. This provides clinicians with a clearer, depth-resolved view of bones and joints, improving diagnostic confidence for detecting issues like occult fractures, determining fracture age, and assessing areas with metal implants. By making this technology accessible within the clinic, the partnership between Nanox and Imperial Imaging aims to streamline the patient journey, enabling surgeons to diagnose, plan treatment, and consult with patients often within a single visit.

This shift is particularly valuable in a busy MSK practice, where immediate answers can significantly improve patient outcomes and operational efficiency. The ability to perform advanced imaging on-site eliminates referral delays and empowers clinicians with greater control over the diagnostic process, directly correlating imaging findings with a patient's physical examination in real-time.

Disrupting the Imaging Landscape

At the heart of this new initiative is the Nanox.ARC's unique value proposition, which combines advanced imaging capabilities with a focus on affordability and safety. The system's multi-source digital X-ray technology is a key differentiator, enabling it to operate at a significantly lower radiation dose compared to traditional CT scans. Clinical data suggests the dose can be as low as 0.1-0.2 millisieverts (mSv), a fraction of the 2 mSv or more associated with a standard CT. This reduction in radiation exposure is a critical consideration for both patients and providers.

Furthermore, Nanox is challenging the high capital costs that have traditionally limited the adoption of advanced imaging equipment in smaller clinics and outpatient centers. The Nanox.ARC is engineered for a smaller footprint—requiring as little as a 15x10 foot room—and is positioned as a cost-effective solution. Nanox has also signaled its intent to utilize an innovative pay-per-scan business model, which would lower the upfront financial barrier for practices, making state-of-the-art 3D imaging a scalable and financially viable option.

The system's credibility is bolstered by multiple regulatory clearances, including a 510(k) from the U.S. Food and Drug Administration (FDA) for a broad range of uses including musculoskeletal, pulmonary, and abdominal imaging, as well as a CE mark for marketing in Europe.

A Strategic Partnership for a Key Market

The choice of Imperial Imaging Technology as a partner is a calculated element of Nanox's U.S. market entry strategy. Founded in 2019, the Georgia-based distributor has demonstrated remarkable growth, earning a spot on the 2025 Inc. 5000 list of fastest-growing private companies. More importantly, Imperial Imaging has cultivated deep relationships and a reputation for high-quality service within the orthopedic community across the Southeast.

By leveraging Imperial's established network and regional expertise, Nanox can more effectively introduce the Nanox.ARC to its target audience. This channel partner strategy allows Nanox to tap into existing trust and clinical understanding, accelerating adoption in a key growth market for orthopedic services.

“We are pleased to welcome Imperial Imaging into our growing network of U.S. distribution partners,” said Erez Meltzer, CEO and Acting Chairman of the Board of Nanox. “This collaboration reflects our commitment to regional strategies that pair advanced imaging technology with trusted, relationship-driven distribution. Imperial Imaging’s strong presence, especially in the orthopedic community, makes them an ideal partner for bringing the Nanox.ARC to more practices and patients across the Southeast.”

Streamlining Care and Patient Access

Perhaps one of the most significant practical advantages of the Nanox.ARC system is its favorable reimbursement status. According to the companies, imaging performed by the system is reimbursable under an existing CPT code and, crucially, does not require pre-authorization from insurers. This detail is a major win for administrative efficiency, as the pre-authorization process is a common source of delays and bureaucratic friction in the U.S. healthcare system. By removing this hurdle, clinics can expedite patient treatment and reduce administrative workloads.

Aaron Pressley, President of Imperial Imaging Technology, highlighted these benefits. “We chose to partner with Nanox for the deployment of multiple systems as the Nanox.ARC aims to support clinicians in revealing new or undetected clinical findings bringing value in orthopedic point of care imaging,” he stated. “The system is reimbursable under an existing CPT code and no pre-authorization is required, which can reduce administrative burden and speed up patient treatment while improving affordability for clinics. We're excited to bring this advanced technology to the orthopedic community across the Southeast.”

For patients, the impact is clear: faster diagnoses, fewer appointments, less travel, and quicker access to necessary care. This partnership ultimately aims to make advanced musculoskeletal diagnostics more accessible and affordable, aligning with Nanox's broader mission to support a global transition toward preventive and efficient healthcare.